A like-for-like comparison for Hip Osteoarthritis — invasiveness, recovery, evidence level and real cost, side by side, so you can see exactly where each option fits.
Direct answer: For Hip Osteoarthritis, Total hip replacement is the proven, regulator-backed option (evidence: Strong) but is more invasive (high) with a longer recovery (8–12 weeks; durable 15–20 years). Stem-cell therapy is less invasive (medium) and cheaper (€5,000–18,000 vs €18,000–40,000), but it is investigational — best considered for earlier-stage disease or when you want to delay or avoid surgery, ideally inside a registered trial.
| Option | Evidencia | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|
| Stem-cell therapy | Investigational | €5,000–18,000 | Medium | 2–4 weeks; early-stage research |
| Total hip replacement | Strong | €18,000–40,000 | High | 8–12 weeks; durable 15–20 years |
Conservative management is the foundation: activity modification (avoiding high-impact exercise), physiotherapy to strengthen hip stabiliser muscles, and weight management to reduce joint load. Analgesics such as paracetamol or NSAIDs (ibuprofen, diclofenac) provide pain control; some patients use topical NSAIDs to minimise systemic side effects. Walking aids and hip supports reduce strain. Intra-articular corticosteroid or hyaluronic-acid injections are effective for moderate OA, though hip anatomy makes injections technically more challenging than in the knee. When conservative measures fail and function is severely compromised, total hip replacement is highly successful and durable, typically lasting 15–20 years.
Stem-cell therapies for hip OA are in early investigation, with research exploring whether bone-marrow or adipose-derived mesenchymal stem cells can reduce inflammation and promote cartilage repair in the hip joint. Hip anatomy and biomechanics differ from the knee, and clinical evidence is limited. Regenerative approaches remain non-standard and candidacy should be evaluated by a hip specialist. Learn more at <a href="../treatments/hip-osteoarthritis.html">regenerative options for hip OA</a> and <a href="../am-i-a-candidate.html">candidate selection</a>.
Neither is universally better. Total hip replacement has the strongest evidence and is definitive, but it is invasive with a 8–12 weeks; durable 15–20 years recovery. Stem-cell therapy is less invasive and cheaper, but unproven — it suits earlier-stage cases or patients avoiding surgery. The right choice depends on your stage, age and goals.
Indicatively €5,000–18,000 for stem-cell therapy versus €18,000–40,000 for Total hip replacement — but cost should never be the deciding factor for an investigational treatment. Always verify GMP certification and approval status first.
No — for Hip Osteoarthritis it is investigational, not an approved cure. Total hip replacement is the established standard of care. Check whether a registered ClinicalTrials.gov trial is open before paying for private treatment.
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita